- Home
- OSCR vs DYN Comparison
OSCR vs DYN Comparison
Compare OSCR & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OSCR | DYN |
|---|---|---|
| Founded | 2012 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Accident &Health Insurance | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.1B |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | OSCR | DYN |
|---|---|---|
| Price | $25.53 | $16.57 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 14 |
| Target Price | $16.88 | ★ $37.00 |
| AVG Volume (30 Days) | ★ 7.3M | 1.4M |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.07 | N/A |
| Revenue | ★ $11,701,427,000.00 | N/A |
| Revenue This Year | $63.89 | N/A |
| Revenue Next Year | $5.30 | N/A |
| P/E Ratio | $11.19 | ★ N/A |
| Revenue Growth | ★ 27.50 | N/A |
| 52 Week Low | $10.69 | $8.25 |
| 52 Week High | $24.28 | $25.00 |
Technical Indicators
Market Signals| Indicator | OSCR | DYN |
|---|---|---|
| Relative Strength Index (RSI) | 85.64 | 39.52 |
| Support Level | $12.18 | $16.57 |
| Resistance Level | N/A | $19.52 |
| Average True Range (ATR) | 1.32 | 0.89 |
| MACD | 0.43 | -0.12 |
| Stochastic Oscillator | 99.62 | 11.58 |
Price Performance
Historical ComparisonAbout OSCR Oscar Health Inc.
Oscar Health Inc is a healthcare technology company built around a full stack technology platform and a relentless focus on serving its members. It offers Individual & Family plans and health technology solutions that power the healthcare industry. Oscar operates as one segment to sell insurance to individuals, families and employees through the federal and state-run healthcare exchanges formed in conjunction with the Patient Protection and Affordable Care Act (ACA) and leverages its technology platform to provide services via its Oscar offering.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.